EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
Upcoming Industry Meetings and Webinars - May 1-31, 2024
-
Here are the industry webinars and events I'm aware of for May 1-31, 2024.
Conferences and bigger events are listed through August 31, 2024 because
they ...
2 days ago
No comments:
Post a Comment